Cargando…
Continuous delivery of propranolol from liposomes-in-microspheres significantly inhibits infantile hemangioma growth
PURPOSE: To reduce the adverse effects and high frequency of administration of propranolol to treat infantile hemangioma, we first utilized propranolol-loaded liposomes-in-microsphere (PLIM) as a novel topical release system to realize sustained release of propranolol. METHODS: PLIM was developed fr...
Autores principales: | Guo, Xiaonan, Zhu, Xiaoshuang, Liu, Dakan, Gong, Yubin, Sun, Jing, Dong, Changxian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609781/ https://www.ncbi.nlm.nih.gov/pubmed/29075111 http://dx.doi.org/10.2147/IJN.S137634 |
Ejemplares similares
-
Significant inhibition of infantile hemangioma growth by sustained delivery of urea from liposomes-in-microspheres
por: Zhu, Xiaoshuang, et al.
Publicado: (2018) -
Propranolol for Infantile Hemangiomas
por: Levy, Moise L.
Publicado: (2012) -
Propranolol for treatment of infantile hemangiomas
por: de Melo, Juliana Nakano, et al.
Publicado: (2013) -
Propranolol in the Treatment of Infantile Hemangiomas
por: Tan, Xin, et al.
Publicado: (2021) -
Mechanisms of propranolol action in infantile hemangioma
por: Kum, Jina JY, et al.
Publicado: (2015)